Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver failure
Biotech
Genfit moves to jump-start enrollment in liver failure trial
Genfit said the changes reflect the comorbidities of people with acute on-chronic liver failure and the logistics of caring for the patients.
Nick Paul Taylor
Sep 20, 2024 9:47am
Rapt faces clinical hold after liver failure in immunology trial
Feb 20, 2024 10:42am
Galecto cans lung fibrosis med after ph. 2 fail, pivots to liver
Aug 15, 2023 7:30am
Genfit revs up liver failure strategy with $41M biotech buyout
Sep 19, 2022 7:00am
Novartis taps Alnylam for ambitious push to fix liver function
Jan 6, 2022 8:00am
FDA approves TransMedics’ donor liver preservation system
Sep 29, 2021 11:38am
